REVIVA PHARMACEUTICALS HOLDINGS CEO Laxminarayan Bhat's 2022 pay slips 7% to $560K
REVIVA PHARMACEUTICALS HOLDINGS reports 2022 executive compensation
By ExecPay News
Published: October 4, 2023
REVIVA PHARMACEUTICALS HOLDINGS reported fiscal year 2022 executive compensation information on October 4, 2023.
In 2022, three executives at REVIVA PHARMACEUTICALS HOLDINGS received on average a compensation package of $440K, a 14% decrease compared to previous year.
Average pay of disclosed executives at REVIVA PHARMACEUTICALS HOLDINGS
Laxminarayan Bhat, Chief Executive Officer, received $560K in total, which decreased by 7% compared to 2021. 71% of Bhat's compensation, or $400K, was in salary. Bhat also received $160K in bonus.
Narayan Prabhu, Chief Financial Officer, received a compensation package of $413K, which decreased by 6% compared to previous year. 67% of the compensation package, or $275K, was in salary.
Marc Cantillon, Chief Medical Officer, earned $349K in 2022, a 31% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on October 4, 2023.